Ufp Technologies UFPT
NASDAQ UFPT
$277.34 -1.25 (-0.45%)
As of: Sep 10, 2026 · 3:59 PM EDT

Ufp Technologies (UFPT) Current Deferred Revenue (2017 - 2026)

Ufp Technologies' (UFPT) quarterly Current Deferred Revenue came in at $4.8 million in Q2 2026, up 4.19% on a YoY basis from $4.6 million in Q2 2025, and up 3.78% quarter-over-quarter from $4.6 million in Q1 2026.

Analysis

Ufp Technologies (UFPT) Current Deferred Revenue (2017 - 2026) Analysis & Trends

Ufp Technologies (UFPT) has reported Current Deferred Revenue for 10 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Deferred Revenue rose 4.19% year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2026 stood at $4.8 million (up 4.19% YoY), and the FY2025 full-year result was $4.2 million, down 9.15% from the prior year.
  • Current Deferred Revenue rose to $4.8 million in Q2 2026 per UFPT's latest filing, from $4.6 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $6.6 million in Q4 2023 and bottomed at $3.6 million in Q1 2023.
  • Historically, Current Deferred Revenue has averaged $4.7 million across 5 years, with a median of $4.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue jumped 157.93% in 2022, then slipped 29.46% in 2024.
  • Over 5 years, Current Deferred Revenue stood at $4.7 million in 2022, then surged by 41.4% to $6.6 million in 2023, then decreased by 29.46% to $4.7 million in 2024, then retreated by 9.15% to $4.2 million in 2025, then advanced by 13.25% to $4.8 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $4.8 million, $4.6 million, and $4.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Ufp Technologies 2.15 Bn 2.14 Bn 50.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.80 Mn
Mar 31, 2026 4.63 Mn
Dec 31, 2025 4.24 Mn
Sep 30, 2025 4.83 Mn
Jun 30, 2025 4.61 Mn
Mar 31, 2025 4.79 Mn
Dec 31, 2024 4.67 Mn
Sep 30, 2024 5.80 Mn
Jun 30, 2024 4.55 Mn
Mar 31, 2024 4.53 Mn
Dec 31, 2023 6.62 Mn
Sep 30, 2023 3.81 Mn
Jun 30, 2023 4.27 Mn
Mar 31, 2023 3.58 Mn
Dec 31, 2022 4.68 Mn
Sep 30, 2022 4.17 Mn
Jun 30, 2022 5.61 Mn
Mar 31, 2022 5.04 Mn
Dec 31, 2021 4.25 Mn
Sep 30, 2021 2.81 Mn